{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T17:47:36Z","timestamp":1764092856529,"version":"3.45.0"},"reference-count":5,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,25]]},"abstract":"<jats:p>We read with great interest the article by Wainman et al., entitled \u2018Is there still a role for clindamycin and rifampicin in the treatment of hidradenitis suppurativa? A review of the literature\u2019. We would like to contribute to this important discussion by offering additional clinical perspectives.<\/jats:p>","DOI":"10.1093\/ced\/llaf357","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T11:52:37Z","timestamp":1753876357000},"page":"2505-2505","source":"Crossref","is-referenced-by-count":0,"title":["Reconsidering clindamycin\u2013rifampicin use in hidradenitis suppurativa: balancing anti-inflammatory benefits and resistance risk"],"prefix":"10.1093","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2915-4666","authenticated-orcid":false,"given":"Sibel","family":"Altunisik Toplu","sequence":"first","affiliation":[{"name":"Infectious Diseases and Clinical Microbiology, Inonu University , Malatya ,","place":["Turkey"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6844-1097","authenticated-orcid":false,"given":"Nihal","family":"Altunisik","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Inonu University , Malatya ,","place":["Turkey"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,7,31]]},"reference":[{"key":"2025112512423765100_llaf357-B1","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1093\/ced\/llaf160","article-title":"Is there still a role for clindamycin and rifampicin in the treatment of hidradenitis suppurativa? A review of the literature","volume":"50","author":"Wainman","year":"2025","journal-title":"Clin Exp Dermatol"},{"key":"2025112512423765100_llaf357-B2","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/jdv.15332","article-title":"Rates of antibiotic resistance\/sensitivity in bacterial cultures of hidradenitis suppurativa patients","volume":"33","author":"Bettoli","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2025112512423765100_llaf357-B3","doi-asserted-by":"crossref","first-page":"e12792","DOI":"10.1111\/dth.12792","article-title":"Clindamycin as unique antibiotic choice in hidradenitis suppurativa","volume":"32","author":"Rosi","year":"2019","journal-title":"Dermatol Ther"},{"key":"2025112512423765100_llaf357-B4","doi-asserted-by":"crossref","first-page":"e150","DOI":"10.1111\/bjd.15500","article-title":"Treatment of hidradenitis suppurativa with rifampicin: have we forgotten tuberculosis?","volume":"177","author":"Mendes-Bastos","year":"2017","journal-title":"Br J Dermatol"},{"key":"2025112512423765100_llaf357-B5","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/jdv.20472","article-title":"European S2k guidelines for hidradenitis suppurativa\/acne inversa part 2: treatment","volume":"39","author":"Zouboulis","year":"2025","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llaf357\/63895703\/llaf357.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/50\/12\/2505\/63895703\/llaf357.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/50\/12\/2505\/63895703\/llaf357.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T17:42:45Z","timestamp":1764092565000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/50\/12\/2505\/8219492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,31]]},"references-count":5,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,7,31]]},"published-print":{"date-parts":[[2025,11,25]]}},"URL":"https:\/\/doi.org\/10.1093\/ced\/llaf357","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"type":"print","value":"0307-6938"},{"type":"electronic","value":"1365-2230"}],"subject":[],"published-other":{"date-parts":[[2025,12]]},"published":{"date-parts":[[2025,7,31]]}}}